[Brain Perfusion, Cognitive Functions, and Vascular Age in Middle Aged Patients With Essential Arterial Hypertension]

V A Parfenov1, T M Ostroumova1, E M Pеrepelova1

  • 1Federal State Budgetary Educational Institution of Higher Education "I. M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation.

Kardiologiia
|June 6, 2018
PubMed

Insights

Middle-aged patients with essential arterial hypertension show impaired cognitive function and reduced cerebral blood flow, correlating with increased vascular age. These findings highlight the impact of hypertension on brain health.

Area of Science:

  • Neuroscience
  • Cardiology
  • Radiology

Background:

  • Essential arterial hypertension (EAH) is prevalent in middle-aged adults.
  • Hypertension can affect cognitive function and cerebral hemodynamics.
  • Vascular age is an indicator of cardiovascular risk.

Purpose of the Study:

  • To evaluate cognitive functions and cerebral blood flow (CBF) using arterial spin labeling (ASL) in untreated EAH patients.
  • To explore the correlation between cognitive function, CBF, and vascular age in EAH.
  • To compare these parameters between EAH patients and healthy controls.

Main Methods:

  • Seventy-three subjects (33 EAH, 40 controls) aged 40-59 years were assessed.
  • Neuropsychological tests included MoCA, Trail Making, Stroop, verbal fluency, and memory tasks.
  • Brain MRI with ASL was performed, and vascular age was calculated using Framingham and SCORE scales.

Main Results:

  • EAH patients exhibited lower phonemic verbal fluency and MoCA scores compared to controls.
  • White matter hyperintensities (WMH) were significantly more common in EAH patients (51.5%) than controls (7.5%).
  • Reduced CBF was observed in the frontal lobes of EAH patients compared to controls.

Conclusions:

  • Untreated EAH is associated with cognitive deficits and reduced frontal lobe CBF.
  • Hypertension significantly impacts brain structure (WMH) and function in middle-aged individuals.
  • These findings suggest a link between EAH, cognitive decline, altered cerebral perfusion, and vascular age.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
240
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
719
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
712
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
263
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
258